CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 205 target
Drug / intervention
online adaptive radiotherapyradiation
Likely dose
Not stated in record
Key inclusion· 3
  • ✓Biopsy-verified anal cancer
  • ✓Eligible for curative intended radiotherapy
  • ✓Written and oral consent
Key exclusion· 1
  • ✕Other malignant disease within past 5 years, excluding basal cell carcinoma

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05438836
NCT05438836N/ARecruitingMonitorUpdated 33mo ago · Completion was 5mo ago
Slow Enrollment
Long Recruiting
Monitor
CompareCT.gov

ROAR-A: Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer

Herlev Hospital·observational·Posted Jun 30, 2022·Updated Sep 25, 2023

In Brief

An observational study evaluating online adaptive radiotherapy for Anal Cancer and 2 related conditions. Currently recruiting, targeting 205 participants across 1 site.

Signals

Enrolling slower than its timeline implies

Detailed Summary

A single-arm, prospective, Phase II, single-center clinical trial that will investigate if daily online adaptive radiotherapy for anal cancer will significantly reduce early treatment-related GI toxicity compared with the historically reported rate for non-adaptive intensity modulated radiation therapy (IMRT).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAnal Cancer, Anal Carcinoma, Anal Squamous Cell Carcinoma
CountriesDenmark
Collaborators--

Timeline

N/ARecruiting
2022202320242025202620272028202920302031
First PostedJun 30, 2022
Enrollment StartJan 1, 2022
Primary CompletionJan 1, 2026
Study CompletionJan 1, 2031
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 4.0 years ago

Interventions

online adaptive radiotherapyradiation

Online adaptive radiotherapy compared to standard non-adaptive Image-Guided Radiotherapy